Sivik Global Healthcare’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Hold
20,000
1.22% 30
2026
Q1
$1.6M Sell
20,000
-15,000
-43% -$1.24M 1.22% 30
2025
Q4
$2.98M Buy
+35,000
New +$2.87M 0.87% 43
2025
Q1
Sell
-50,000
Closed -$3.7M 38
2024
Q4
$3.7M Buy
+50,000
New +$3.5M 1.95% 25
2024
Q3
Sell
-60,000
Closed -$5.54M 40
2024
Q2
$5.54M Sell
60,000
-10,000
-14% -$886K 1.99% 21
2024
Q1
$6.69M Buy
+70,000
New +$5.88M 1.57% 16
2022
Q1
Sell
-15,068
Closed -$1.95M 54
2021
Q4
$1.95M Buy
+15,068
New +$1.76M 0.84% 42
2020
Q1
Sell
-45,000
Closed -$3.5M 49
2019
Q4
$3.5M Sell
45,000
-30,000
-40% -$2.34M 1.3% 37
2019
Q3
$5.5M Sell
75,000
-18,000
-19% -$1.26M 2.77% 16
2019
Q2
$5.73M Buy
93,000
+45,000
+94% +$2.72M 1.38% 15
2019
Q1
$3.06M Buy
+48,000
New +$2.74M 1.13% 43
2018
Q1
Sell
-60,000
Closed -$2.25M 62
2017
Q4
$2.25M Buy
+60,000
New +$2.2M 0.84% 53
2017
Q1
Sell
-45,000
Closed -$1.41M 60
2016
Q4
$1.41M Buy
+45,000
New +$1.46M 0.67% 46
2016
Q2
Sell
-60,000
Closed -$1.76M 59
2016
Q1
$1.76M Buy
+60,000
New +$1.66M 0.78% 50

Other funds holding EW

Sivik Global Healthcare's EW Position: Q2 2026 in Review

Sivik Global Healthcare held its Edwards Lifesciences (EW) position steady in Q2 2026 at 20,000 shares worth $1.6M. The position accounts for 1.22% of the portfolio, ranked #30.

Sivik Global Healthcare first reported a position in EW in Q1 2016 and has held it in 14 quarters since. The position peaked at $6.69M in Q1 2024. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sivik Global Healthcare held 20,000 shares of Edwards Lifesciences worth $1.6M as of Q2 2026.
  • Sivik Global Healthcare left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 1.22% of Sivik Global Healthcare's portfolio in Q2 2026, its #30 holding.
  • Sivik Global Healthcare first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 14 quarters since.
  • Sivik Global Healthcare's Edwards Lifesciences position peaked at $6.69M in Q1 2024.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.